Genfit SA

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

21 Jan 2022 15:10:00 By Nasdaq GlobeNewswire

On heels of global strategic partnership announced today, GENFIT acquires rights to novel asset

17 Dec 2021 00:15:00 By Nasdaq GlobeNewswire

GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients with “at-risk” NASH

18 Nov 2021 15:15:00 By Nasdaq GlobeNewswire

GENFIT Announces First Patient First Visit for the Evaluation of NTZ in Subjects with Hepatic Impairment as part of its ACLF Program

09 Nov 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT: Third Quarter 2021 Financial Information

08 Nov 2021 15:10:00 By Nasdaq GlobeNewswire

New Clinical Data on GENFIT’s Investigational Compound Elafibranor to be Presented at AASLD The Liver Meeting®

02 Nov 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update

29 Sep 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

09 Jul 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT: June 30, 2021 Annual Shareholders Meeting results

30 Jun 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT obtains non-dilutive financing of €11 million in the form of a State Guaranteed Loan

24 Jun 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT presents new NIS4® data in NASH at the International Liver Congress™ and the 81st Scientific Sessions of the American Diabetes Association

23 Jun 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT: June 15, 2021 Combined Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening

15 Jun 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT Informs its Shareholders of Certain Procedures for the Combined General Meeting of June 15, 2021

27 May 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT: Reports First Quarter 2021 Financial Information

12 May 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT Provides Pipeline Update and Launch of New Clinical Programs

11 May 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT Annual Combined General Meeting of June 15, 2021 - Availability of Preparatory Documents

10 May 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered by GENFIT’s NIS4™ Technology to Identify Patients with At-Risk NASH

03 May 2021 01:10:00 By Nasdaq GlobeNewswire

GENFIT: Publication of the 2020 Universal Registration Document and the 2020 Annual Report on Form 20-F; Annual Shareholders Meeting to take place on June 15, 2021

23 Apr 2021 11:30:00 By Nasdaq GlobeNewswire

GENFIT hires Thomas Baetz as Chief Financial Officer and adds two new members to its Executive Committee

22 Apr 2021 15:10:00 By Nasdaq GlobeNewswire

GENFIT Reports Full-Year 2020 Financial Results and Provides Corporate Update

01 Apr 2021 15:10:00 By Nasdaq GlobeNewswire